Taking Shortcuts in Drug Testing Can Put Patients at Risk

Using surrogate endpoints can speed up testing of new drugs, but doesn’t always find out if they actually help patients.

from NPR

There is growing interest in reducing the evidence required to approve new drugs and to more rapidly deliver new therapies to patients. The sentiment behind speeding approval is a good one—no one wants to delay the availability of drugs that are beneficial and safe—but can lead to shortcuts in evidence generation that can also come with risk.

Read More →

Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.